![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Optimal Non-Invasive Screening Strategy for Nonalcoholic Fatty
Liver Disease in a Prospective Cohort of Patients with Type 2
Diabetes
|
|
|
EASL 2020 Aug 27-29 virtual Reported by Jules Levin
V. Ajmera 1, J. Jung 1, K. Purohit 1, S. Lopez 1, S. Bajwa-Dulai 2, R. Bettencourt 1, L. Richards 1, K. Fowler 3, C. Sirlin 3 and R.
Loomba 1
1. NAFLD Research Center, University of California, San Diego
2. Internal Medicine, University of California, San Diego
3. Liver Imaging Group, University of California, San Diego
![0925201](../images/092520/092520-1/0925201.gif)
![0925202](../images/092520/092520-1/0925202.gif)
![0925203](../images/092520/092520-1/0925203.gif)
![0925204](../images/092520/092520-1/0925204.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|